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Nasopharyngeal carcinoma (NPC) is an endemic cancer with a
very high incidence in South China and Southeast Asia such as
Hong-Kong and Taiwan. Epstein-Barr virus (EBV), genetic
factors (human HLA type A2-BW42 and cytochrome p4502E1-
CYP2E1), and certain dietary (nitrosamine, herbal medicine) and
environmental conditions (smoking, occupational exposures) 
have been shown to be involved in the development of NPC
(Hildesheim and Levine, 1993), but the molecular mechanisms 
by which NPC was generated remained largely unknown. Over-
expression of Myc oncogene was detected in NPC cell lines (Lin
et al, 1993) and in some NPC tumours (Porter et al, 1994). Bcl-2
was up-regulated and was detected in most samples of NPC 
(Lu et al, 1993). Mutations in p53 tumour suppressor gene (Spruck
et al, 1992) and RB/p105 gene (Sun et al, 1993) in NPC are rela-
tively rare. Lately, mutations in the RB2/p130 gene were detected
in 30% of primary human NPCs (Claudio et al, 2000). Though
decreased level of expression was reported, no point mutation of
the potential tumour suppressor gene p16 was detected in NPC
(Sun et al, 1995). These studies suggested the importance of other
genes in NPC oncogenesis. 
Various tools such as cytogenetic analysis (Mitelman et al,
1983; Huang et al, 1989), loss of heterozygosity (LOH) (Huang 
et al, 1991; Hu et al, 1996; Mutirangura et al, 1997), and compara-
tive genomic hybridization (CGH) (Chen et al, 1999; Hui et al,
1999) have been employed to investigate the candidate genes
associated with NPC. These studies offered a genome-wide inves-
tigation based upon a comprehensive pattern of DNA sequence
copy number changes. Alterations due to mutations and/or regula-
tion dysfunction can hardly be detected. Differential display (DD)
(Fung et al, 1998) and cDNA representational difference analysis
(RDA) (Zhan et al, 1998) offered alternative screening tools. We
had adopted differential display for the study of differences in
gene-expression patterns between normal nasal epithelial and
transformed nasopharyngeal epithelial cells. The elevated expres-
sion of TR-α 2 in NPC cell lines was demonstrated. RNA in situ
hybridization of TR-α 2 transcripts among biopsies derived from
NPC cases and control subjects was employed to substantiate the
in vitro finding. 
MATERIALS AND METHODS 
Cell culture 
Biopsied tissues of nasal polyps and turbinates were collected
from National Taiwan University Hospital and Mackay Memorial
Hospital, Taipei. After removal of blood clots with three washes of
sterile phosphate buffered saline (PBS), these samples were added
into Dulbecco’s minimum essential medium (DMEM) supple-
mented with 0.1 mM nonessential amino acids, 50 U ml–1
penicillin, 50 µ g ml–1 streptomycin, 1.25 µ g ml–1 fungizone and
1 mg ml–1 pronase. After an overnight incubation at 4˚C, carcass
was discarded and the suspension was centrifuged at 1,500 rpm for
10 min at room temperature. The pelleted cells were resuspended
in DMEM supplemented with 10% fetal bovine serum, 0.1 mM
nonessential amino acids, 50 U ml–1 penicillin, 50 µ g ml–1 strepto-
mycin, 1.25 µ g ml–1 fungizone, and inoculated onto collagen
coated plates. Attached cells were grown to 70–80% confluence at
37˚C and served as normal epithelial cells control. Cytokeratin
staining was employed to verify the nature of the attached cells.
More than 95% of the attached cells showed positive cytokeratin
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staining, demonstrating epithelial cells origin. NPC cell lines,
HONE-1 (Glaser et al, 1989), NPC-TW01 (Lin et al, 1990) and
NPC-TW04 (Lin et al, 1993), were all grown at the same condi-
tion. LCL, EBV-immortalized lymphoblastoid cells, was kindly
provided by Dr Chin-Hwa Tsai at the Graduate Institute of
Microbiology, National Taiwan University. 
Differential display (DD-PCR) 
Total RNAs were extracted from cells grown at 70–80% conflu-
ence according to the method described by Chomczynski and
Sacchi (Chomczynski and Sacchi, 1987). 50 micrograms of total
RNAs were treated with 10 units of RNase free DNase, extracted
with phenol/CHCl3, and precipitated with ethanol. The reverse
transcription and PCR reaction were performed as described 
by manufacturer’s instruction (RNAimage Kit, GenHunter Cor-
poration). Briefly, reverse transcription was done in the reaction
mixtures containing 2 µ g total RNAs, 50 mM Tris, pH 8.3, 3 mM
MgCl2, 75 mM KCl, 10 mM DTT, 0.02 mM each dNTP, 2.5 µ M
H-T11N (5′ -AAGCTTTTTTTTTTTN-3′ , N = A, G, or C), 
20 U RNase inhibitor, and 200 U MMLV-RT (Life Technologies)
in a volume of 20 µ l at 35˚C for 1 h. After the reaction, the whole
mixture was heated to 94˚C for 5 min, followed by dilution of the
reverse transcription reaction mixture to 200 µ l. Two microlitres
of the dilution mixture was combined with 20 µ l reaction mixture
containing 10 mM Tris-HCl, pH 8.8, 1.5 mM MgCl2, 50 mM KCl,
0.1% Triton-X100, 2 µ M each dNTP, 2.5 µ M H-T11N, 0.5 µ M
arbitrary 13 mers (H-AP1 to H-AP80), 2.5 U Taq polymerase
(DYNAZYME, Finnzymes Inc, Finland), 10 µ Ci  α -35S-dATP
(>1000 Ci mmol–1, Amersham Pharmacia Biotech) for PCR. The
PCR products were separated in a 6% DNA sequencing gel 
and visualized by autoradiography. Bands of interest were cut 
out from the polyacrylamide gel, and the eluted and reampli-
fied  cDNA fragments were cloned into the EcoRV-cut and 
T-tagged pBluescript SK vector (Stratagene). For each fragment, 
6 to 10 colonies containing inserts of correct size were chosen 
for sequence analysis and homology search with nucleic acid 
data bank. 
Northern analysis 
Poly-A(+) RNA were purified through affinity chromatography on
oligo-(dT)-cellulose (Life Technologies). 20 µ g of total RNAs and
5 µ g of poly-A(+) RNA were size-fractionated on 1% agarose gel
containing formaldehyde, blotted on Hybond-NTM membrane
(Amersham Pharmacia Biotech). The blot was hybridized with
32P-labelled probes and exposed to phosphor-screen (Molecular
Dynamics) and scanned using PhosphoImager (STORM 840,
Molecular Dynamics). The same blots were stripped and reprobed
with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an
internal control. 
Southern blot analysis 
20 micrograms of total DNAs extracted from NPC cell lines 
or LCL were digested with Eco RI,  Hind III,  Pst I or Xho I,
separately. DNA fragments were separated in a 1% agarose 
gel electrophoresis and transferred to Hybond-NTM membrane.
The membrane was hybridized with 32P-labelled rat TR-α 1 
cDNA fragment and visualized by PhosphoImager (Molecular
Dynamics). 
Plasmid and cRNA probe preparation 
EST clone (IMAGE clone Id 42706), containing nt. 356–2015 of
TR-α 2 cDNA (gene bank accession no. j03239) was purchased
from Genome Systems, Inc, sequenced and matched to TR-α 2
cDNA as reported. An approximately 600 bp (nt. 1410–2015)
DNA fragment, covering the unique region of TR-α 2, was isolated
after EcoRI digestion and ligated into EcoRI-cut pBluescript SK
vector, generating pTRα 2CSK. The fragment was inserted in an
orientation so that sense strand can be transcribed by T3 RNA
polymerase and anti-sense strand can be transcribed by T7 RNA
polymerase. pTRα 2CSK was linearized with BamHI or HindIII
and served as template for antisense or sense riboprobe synthesis,
respectively. The riboprobe synthesis was performed in a 20 µ l
reaction containing 1 µ g DNA template, 1 mM ATP, CTP, and
GTP, 0.65 mM UTP, 0.35 mM digoxigenin-11-UTP, 50 units 
of RNase inhibitors, 40 units of T3 or T7 RNA polymerase
(Boehringer Mannheim) in transcription buffer at 37˚C for 1 hour.
The reaction was terminated by incubation with 2 units of RNase-
free DNase I (Life Technologies) for 15 minutes at 37˚C. The
digoxigenin-labelled probe was precipitated with ethanol and
dissolved in DEPC-treated water. 
Specimens 
The present work comprised 27 primary NPC patients and 
24 radio- or chemotherapy treated and recurrent NPC patients.
Nasopharyngeal tissues from patients with chronic inflammation
but without evidence of tumours were used as source of normal
nasopharyngeal epithelium. The histological diagnosis of all
patients was confirmed by pathologist. Histopathological classifi-
cation of all cases was performed according to WHO classifica-
tion. All specimens were received from pathology file of National
Taiwan University Hospital and fixed in 10% neutralized formalin
and embedded in paraffin. 
RNA in situ hybridization 
5 µ m of paraffin-embedded sections were deparaffinized in xylene
and hydrated to 50% ethanol then dried, after which they were
treated with prewarmed 20 µ g ml–1 proteinase K for 10 min at
50˚C, washed with water. The slides were dipped into freshly
prepared 0.25% acetic anhydride in 0.1 M triethanolamine, pH 8.0,
for 10 minutes, washed with phosphate buffered saline (PBS),
DEPC-treated water, then dried. The sections were incubated with
a final concentration of 0.5 ng ml–1 denatured digoxigenin-labelled
sense or antisense riboprobes in hybridization buffer (50%
formamide, 5 × SSC, 10% dextran sulphate, 2% SDS, 1% PVP, 5 ×
Denhardt’s solution, 100 µ g ml–1 denatured salmon sperm DNA)
at 42˚C for 16–18 hours. The sections were then washed in 1 ×
SSC and 0.2 × SSC/0.01% SDS at room temperature for 5 min,
followed by washing in 0.05 × SSC at 50˚C for 5 min, and 0.025 ×
SSC at 55˚C for 15 min. After advanced incubation in buffer 1
(100 mM Tris-HCl, 150 mM NaCl, pH 7.5), sections were blocked
with 2% blocking reagent (Boehringer Mannheim) for 1 hour at
room temperature, then washed in buffer 1. Anti-digoxigenin anti-
body conjugated with alkaline phosphatase at 1:200 dilution in
buffer 1 containing 1% swine serum was applied onto the sections
for 1 hour at room temperature. Subsequently, the sections were
washed in buffer 1 and buffer 2 (100 mM Tris-HCl, 100 mM 
NaCl, 50 mM MgCl2, pH 9.5) for 5 min at room temperature,respectively. Finally, in situ signal was developed with NBT/BCIP
solution (Boehringer Mannheim) and nuclear fast red was utilized
as a counterstain reagent. Two-tailed, Fisher’s exact test was used
for statistical analysis, and a P value of less than 0.05 was graded
as statistically significant. 
RESULTS 
NPC, also termed as ‘lymphoepithelioma’, is characterized by the
close association of lymphoid cells and transformed epithelial
cells. To avoid the complication of the heterogeneous cell compo-
sition of clinical NPC specimens, we used the established cultured
NPC cells: HONE-1 (Glaser et al, 1989), NPC-TW01 (Lin et al,
1990), and NPC-TW04 (Lin et al, 1993) for the DD assay. Due to
the difficulty in collecting a critical mass of normal epithelial cells
from nasopharynx, primary epithelial cells cultured from polyps
and turbinates were utilized as normal controls. Although they
were derived from different anatomical sites, they were all charac-
terized as pseudostratified columnar respiratory epithelial cells. 
In this study, a total of 144 primer pair combinations were
finished and 597 cDNA fragments were collected. Of these, 54
cDNA fragments were tested in the Northern blot analysis and 16
were confirmed to be differentially expressed. Results of homology
search using the Blast program were listed in Table 1. Six of these
sequences were found to show significant homology with EST
clones without known function. The remainder matched to the
following sequences: cadherin-6, caldesmon, laminin, glutamin
synthetase, tropomyosin, c-erb A-α 2, cyclin B, lactate dehydro-
genase B, cyclin B2, and PTI-1. The 130 bp cDNA fragment
(designated T11CAP2NPCl-8), identified in all three NPC cell lines
(Figure 1A), showed 98% homology with the 3′ -untranslated region
of human TR-α 2 (c-erb A-α 2) (Nakai et al, 1988) (Figure 1B).
When utilized as a probe, a 2.7 kb transcript was detected in all three
NPC cell lines (Figure 2A, lanes 1–3) but not in normal control
obtained from a randomly-picked individual (Figure 2A, lane 4) or
pooled samples (Figure 2A, lane 5). In order to examine whether
TR-α 2 (c-erb A-α 2) was indeed differentially expressed, the poly
A+ RNAs were extracted and probed with a cDNA fragment (nts.
1410–2015) of TR-α 2 (IMAGE clone Id 42706). As expected, the
2.7 kb transcript was exclusively detected in HONE-1 cells (Figure
2B, lane 1) but not in normal control (Figure 2B, lane 2). 
TR-α 2 gene has been mapped to chromosome 17q11.2.
Significant chromosome gains at 17q in NPC biopsy specimens
have been found using comparative genomic hybridization (CGH)
(Chen et al, 1999). DNA amplification induced-elevation in 
TR-α 2 expression level was suspected. Southern blot analysis was
1676 J-W Lee et al
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Table 1 Results of homology search of the 16 differentially expressed cDNA fragments 
Source derived from cDNA fragment Fragment size (bp)  Homology search Size of transcripta
Cultured normal nasal epithelial cells T11GAP5N5c-8 400 Cadherin-6 8 kb 
4 kb 
T11CALtk3CN3 379 AA610677b 3.5 kb 
T11GAP5N5b 550 Caldesmon 2 kb 
5 kb 
T11GAP6N6c 350 laminin 5 kb 
T11GAP6N6d-19 280 AW614173b 4.8 kb 
T11AAP2N2d-1 420 Glutamin synthetase 3 kb 
T11AAP8N8a-3 620 Tropomyosin isoform mRNA 2 kb 
NPC cell lines T11CAP2NPC1-8 130 c-erb A-α 2 (TR-α 2) 2.7  kb 
T11GAP2NPC2d 500 N48003b 4 kb 
T11GAP2NPC2e 400 AA282043b 1 kb 
T11GAP3NPC3d 500 Cyclin B 1.8 kb 
T11GAP7NPC7j-4 260 AA340599b 2 kb 
5 kb 
T11CAP9NPC9b-5 420 Lactate dehydrogenase 1 kb 
T11CAP10NPC10b-1 700 Cyclin B2 2 kb 
T11CAP11NPC11c 450 AA411599b 2 kb 
T11CAP13NPC13a 350 PTI-I 4.8 kb 
2.1 kb 
0.5 kb 
asize estimated by Northern blot analysis using 32P-labelled cDNA fragment designated in the same row. bEST clone. 
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Figure 1 Band pattern and sequence alignment of T11CAP2NPC1-8 cDNA
fragment with c-erb A-α 2. (A) Band pattern from a part of the sequencing 
gel in differential display of mRNAs from three NPC cell lines: HONE-1, 
NPC-TW01, NPC-TW04 and cultured normal nasal epithelial cells derived
from 7 individual. Arrow indicates T11CAP2NPC1-8 cDNA that is expressed 
in all three NPC cell lines but not in normal cultured epithelial cells. 
(B) Sequence alignment of T11CAP2NPC1-8 cDNA fragment with c-erb A-α 2.
Sequences of primers employed to generate the cDNA fragment are
underlined. The numbering of c-erb A-α 2 sequences is based upon that
reported by Nakai et al. (1988) performed to investigate the genomic organization of TR-α gene
in NPC cell lines. No amplification or obvious DNA rearrange-
ment was observed (Figure 3). 
Due to the complication of heterogeneous cell population in
biopsies, RNA in situ hybridization, instead of Northern blot
analysis or RT-PCR, was utilized to examine the status of TR-α 2
expression. The present study included biopsies obtained from 27
patients with primary NPC, 24 patients with recurrent NPC, and 24
patients with chronic inflammation but without evidence of
neoplasm. The clinical and pathological features are listed in 
Table 2. 22 (81.5%) of the primary and 19 (79.2%) of the recurrent
tumours were classified as undifferentiated carcinoma (WHO type
III), 5 (18.5%) of the primary and 4 (16.7%) of the recurrent
tumours were non-keratinizing carcinoma (WHO type II). The sex
distribution was 20 (74.1%) males, 7 (25.9%) females in the 
primary tumours, and 20 (83.3%) males, 4 (16.7%) females in
the recurrent tumours. Sense or anti-sense riboprobes covering the
unique region (nts. 1410–2015) of TR-α 2 were used for RNA in
situ hybridization. When more than 10% of the epithelial cells
were stained purple-red, it was scored as positive (Figure 4). 
The results are summarized in Table 2. One of 24 (4.2%) 
normal nasopharyngeal specimens, 5 of 27 (18.5%) primary NPC
tumours, and 15 of 24 (62.5%) recurrent tumours exhibited posit-
ive staining. Expression of TR-α 2 was not correlated with histo-
logical type or clinical stage of tumours. The difference between
normal controls and the recurrent NPC tumours was statistically
significant (P < 0.00001, two-tailed Fisher’s exact test). A signifi-
cant difference was observed between recurrent and primary NPC
tumours (P = 0.0018). The difference in frequency between
normal controls (4.2%) and the primary NPC tumours (18.5%)
was statistically not significant (P = 0.106), possibly due to the
limitation of sample size. 
DISCUSSION 
We have applied the mRNA differential display method to identify
genes differentially expressed in cultured NPC or normal nasal
epithelial cells. Among the 597 fragments collected, 54 were tested
in Northern blot analysis and 16 were confirmed to be differentially
expressed (Table 1). Several distinct sequences have been identified
by Fung et al (1998) using the same approach. Representational
difference analysis employed by Zhan et al (1998) revealed several
sequences too. However, not a single sequence was identical
among these two and our studies, possibly due to the utilization of
different cell culture conditions or primer sets used. 
Among those 16 listed in Table 1, TR-α 2 attracted us most.
Thyroid hormone receptors (TRs) are members of nuclear
hormone receptors. Nuclear hormone receptors, such as oestrogen
receptor (ER), androgen receptor (AR), have been implicated in
the outgrowth of tumour cells. Abnormal nuclear receptors are
involved in a variety of cancers, including human acute promyelo-
cytic leukaemia, which is caused by chromosomal translocations
resulting in fusion of RARα to other cellular proteins (Warrell 
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Figure 2 Northern profiles of c-erb A-α 2 (TR-α 2) gene specifically
expressed in NPC cell lines. (A) 20 micrograms of total RNAs from NPC cell
lines: HONE-1 (lane 1), NPC-TW01 (lane 2), NPC-TW04 (lane 3), cultured
epithelial cells of polyps from a normal individual (lane 4) and pooled controls
(lane 5) were loaded into indicated lanes of 1% agarose gel containing
formaldehyde. A 2.7 kb transcript was detected in all three NPC cell lines
when probed with 32P-end-labelled cDNA fragment (T11CAP2NPC1-8)
obtained from DD-PCR cloning. The same blot was reprobed with GAPDH as
an internal control and shown at the bottom. (B) Five micrograms of poly-A(+)
RNAs from H: HONE-1 (lane 1) or N: cultured normal epithelial cells (lane 2)
were loaded into 1% agarose containing formaldehyde. The 2.7 kb transcript
was detected in HONE-1 cell but not in cultured normal epithelial cells when
probed with 32P-labelled cDNA fragment containing the unique region (nts
1410 to 2015) of c-erb A-α 2 (TR-α 2) gene. The same blot was reprobed with
GAPDH as an internal control and shown at the bottom 
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Figure 3 Southern blot analysis revealing similar TR-α genomic
organization between HONE-1 and LCL cell lines. 20 micrograms of DNA
extracted from LCL (lanes 1-4) or HONE-1 cells (lanes 5–8) were digested
with Eco RI (E), Xho I (X), Pst I (P) or Hind III (H) separately, and loaded into
1% agarose gel. After electrophoresis, the separated DNA fragments were
transferred to Hybond-NTM membrane and hybridized with 32P-labelled TR-α
cDNA probes et al, 1994). TR-α 2 (c-erb A-α 2) is an alternatively spliced variant
of the TR-α 1 (c-erb A-α 1) gene (Lazar et al, 1988; Mitsuhashi et
al, 1988). TR-α 2 (c-erb A-α 2) is unable to bind T3 and has been
shown to exert dominant negative action of T3/TRs-dependent
transactivation of target genes (Koenig et al, 1989; Lazar et al,
1989). This dominant negative effect is similar to that observed for
the oncoprotein v-erb A, whose C-terminal mutations render it
unable to bind T3 (Damm, 1993). The dominant negative v-erb A
contributes to the development of erythroblastic leukaemia 
after infection with avian erythoblastosis virus. Hepatocellular
carcinoma was observed in male mice transgenic for v-erb A
(Barlow et al, 1994), demonstrating that v-erb A can promote
neoplasia in mammals. By analogy with its dominant negative
action on T3/TRs-dependent transcription to v-erb A, TR-α 2 
(c-erb A-α 2) might contribute certain roles in the unstrained
growth phenotype. In fact, increased expression of c-erb A-α 2
mRNA was reported in transformed rodent cells when compared
with their non-transformed counterparts (Too and Guernsey,
1992). Lately, the high prevalence of TR mutations was reported
in tumour cells of hepatocellular carcinoma, suggesting that the
mutant TRs could play an important role in liver carcinogenesis
(Lin et al, 1999). The evidence for direct linkage of abnormal TR-
α 2 expression with human neoplasm is absent. This is the first
report describing the association of elevated TR-α 2 expression
with nasopharyngeal carcinoma. Studies are in process to
determine whether the elevated expression of TR-α 2 in NPC cells
did provide the cells with a selective growth advantage. 
Southern blot analysis indicated that there was no amplification
or obvious genomic organization change of TR-α gene (Figure 3)
in NPC cell lines. The exact mechanism by which TR-α 2 expres-
sion level was elevated in NPC cell lines remains to be elucidated.
Small genomic lesions such as mutations, deletions awaits detailed
sequencing analysis. 
RNA in situ hybridization revealed a moderate increase in
percentage of positive TR-α 2 expression in primary NPC speci-
mens (18.5%) compared to that in normal control (4.2%). Though
the difference was statistically not significant, the number and
intensity of positive TR-α 2 staining in primary NPC specimens
were consistently higher and stronger than normal control.
Whether elevated expression of TR-α 2 is causally related to or
merely a consequence of the development of NPC requires further
examination. The result that merely one-fifth of the primary NPC
specimens demonstrated TR-α 2 expression implies the involve-
ment of other genes in the development of NPC. 
The finding that a high percentage of biopsies derived from recur-
rent NPC tumours were scored positive (15 in 24) for TR-α 2 expres-
sion is interesting. Most NPC cases are initially treated with
radiotherapy or chemotherapy, cancer recurrence usually implies
that tumour cells have escaped from cytotoxic effects of radiation or
chemotherapy. While the result offered evidence for increased
1678 J-W Lee et al
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Figure 4 RNA in situ hybridization showing c-erb A-α 2 (TR-α 2) expression in NPC but not in normal nasopharynx epithelium. Five µ m of paraffin-embedded
normal nasopharynx epithelium (A,B,C), and NPC tumour (D,E,F) sections were applied with digoxigenin-11-UTP labelled sense (B,E) or antisense (C,F)
riboprobes of TR-α 2 gene and developed with NBT/BCIP solution. Nuclear fast red was used as counterstain reagent. ➨ indicated positive staining. HE staining
(A,D) of sections are shown in the first row. NPE: normal nasopharynx epithelium, Lym: infiltrated lymphocytes, TC: nasopharyngeal carcinoma cells. Original
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tolerance to cytotoxic challenge in NPC cells with TR-α 2 expres-
sion, the possibility of radio-/chemotherapy-induced changes and
subsequently elevated expression level of TR-α 2 can not be
excluded. 
In addition to studies based on DNA/chromosome alterations,
study such as this RNA-based screening method offered an alter
native and supplementary way to identify putative NPC-related
oncogenes or tumour suppressor genes. The current study using
RNA-based differential display in conjugation with clinical biopsy
studies revealed TR-α 2 as a candidate gene and provided a
feasible approach for the search of the NPC-related molecules. 
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